1. Home
  2. NWPX vs ENGN Comparison

NWPX vs ENGN Comparison

Compare NWPX & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NWPX

Northwest Pipe Company

HOLD

Current Price

$74.67

Market Cap

722.9M

Sector

Industrials

ML Signal

HOLD

Logo enGene Holdings Inc.

ENGN

enGene Holdings Inc.

HOLD

Current Price

$9.83

Market Cap

605.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NWPX
ENGN
Founded
1966
1999
Country
United States
Canada
Employees
N/A
N/A
Industry
Steel/Iron Ore
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
722.9M
605.5M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
NWPX
ENGN
Price
$74.67
$9.83
Analyst Decision
Buy
Buy
Analyst Count
2
7
Target Price
$60.00
$22.71
AVG Volume (30 Days)
91.2K
473.3K
Earning Date
02-25-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
24.50
N/A
EPS
3.66
N/A
Revenue
$519,991,000.00
N/A
Revenue This Year
$8.18
N/A
Revenue Next Year
$1.02
N/A
P/E Ratio
$20.26
N/A
Revenue Growth
7.64
N/A
52 Week Low
$36.97
$2.65
52 Week High
$77.43
$12.25

Technical Indicators

Market Signals
Indicator
NWPX
ENGN
Relative Strength Index (RSI) 63.92 53.30
Support Level $68.13 $9.30
Resistance Level $77.43 $10.20
Average True Range (ATR) 2.44 0.88
MACD 0.32 -0.07
Stochastic Oscillator 63.53 41.30

Price Performance

Historical Comparison
NWPX
ENGN

About NWPX Northwest Pipe Company

NWPX Infrastructure Inc is a manufacturer of water-related infrastructure products. The Company is the manufacturer of engineered water transmission systems in North America and produces steel casing pipe, bar-wrapped concrete cylinder pipe, and pipeline system joints and fittings through its Engineered Steel Pressure Pipe segment. The Company provides solution-based products for a wide range of markets, including high-quality reinforced precast concrete products, lined precast sanitary sewer system components, water distribution and management equipment, including pump lift stations, wastewater pretreatment, and stormwater quality products through its Precast Infrastructure and Engineered Systems segment.

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC). The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Share on Social Networks: